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Brandt, W i l l i a m J. Rodriguez, Uyun W. Kim, J u l i t a O m i o , Barbara C. J e f f r i e s , Mary K. Gardner, Robert H. P a r r o t t . t h i l d r e n ' s H o s~i t a l and t h e Georae Washinaton U n i v e r s i t v School o f ~e d i c i n e and H e a l t h sciences, washington, U. C;
There i s a need f o r t h e r a p i d r e c o g n i t i o n o f i n f e c t i o n by t h e newly-described e n t e r a l o r d i a r r h e a -a s s o c i a t e d adenovir u s e s (adenoviruses t h a t a r e o f proposed n e u t r a l i z i n g serot y p e s 4 0 and 41, o r t h a t have r e s t r i c t i o n endonuclease e l e ct r o p h o r e t i c p r o f i l e s o f Wadell groups F o r G).
These v i r u s e s e s p e c i a l l y i n f e c t i n f a n t s , and t h e y t e n d t o be f a s t i d i o u s i n t h e i r growth i n conventional c e l l c u l t u r e s .
D u r i n g a 6 m i n u t e viewing p e r specimen, adenoviruses were v i s u a l i z e d by d i r e c t e l e c t r o n microscopy (EM) o r i~nmune EM i n t h e s t o o l s o f 52 p e d i a t r i c i n p a t i e n t s w i t h acute gastroent e r i t i s .
F o r t y (77%) o f these v i r u s e s proved t o be e n t e r a l adenoviruses on t h e b a s i s o f n e u t r a l i z a t i o n t e s t i n 293 c e l l s and/or e l e c t r o p h o r e t i c p r o f i l e .
However, o n l y 5 (36%) o f 14 p a t i e n t s w i t h l e s s t h a n 1 adenovirus p a r t i c l e p e r minute o f d i r e c t EM v i e w i n g o f t h e o r i g i n a l d i a r r h e a s t o o l s were found t o have an e n t e r a l adenovirus, as compared t o 35 (92%) o f 38 p a t i e n t s w i t h 1 o r more such p a r t i c l e s per minute o f v i e w i n g (~2 = 18.34, P = < .01). Thus t h e q u a n t i t y o f adenoviruses found i n a d i a r r h e a s t o o l would appear t o p r o v i d e a s t r o n g presumptive i n d i c a t i o n o f t h e presence o r absence o f an e n t e r a l adenovirus.
This d e t e r m i n a t i o n can be made w i t h i n 1 5 m i n u t e s o f specimen c o l l e c t i o n . Approximately 5-10% of infants infected in utero with cytomegalovirus (CMV) exhibit clinically apparent disease at birth with the remainder having subclinical infection. Although the maternal immune response has been implicated as a virulence factor in congenital infection, conventional serologic techniques have failed to clarify the role of transplacentally acquired maternal anti-CMV antibodies in the prevention of symptomatic congenital infection. To further elucidate the effect of maternal antibody on the development of symptomatic infection, we have utilized the Western immunoblot procedure to investigate both the quantity and the antigen-specificity of anti-CMV antibodies in the cord sera of 6 infants with symptomatic disease and 10 asymptomatic, congenitally infected infants. Both groups acquired CMV as a result of primary maternal infection. Antibodies directed against virion glycoproteins and capsid proteins were detected in both groups; however as a group, a stronger response was noted in sera from asymptomatic infants. Unexpectedly, maternal sera obtained at delivery from 12/16 of the infants contained a greater quantity of anti-CMV antibodies as well as reacting with additional virion proteins not detected by cord sera. These results indicated that transplacental passage of maternal anti-CMV antibodies was incomplete in the majority of infants studied. Furthermore, our findings suggested that maternal antibodies may play a role in the prevention of symptomatic congenital CMV infection which was not previously appreciated. 
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TREATMENT OF PATIENTS WITH RECURRENT TONSILLITIS
DUE TO GROUP A BETA HEMOLYTIC STREPTOCOCCI: A PROS-PECTIVE RANDOMIZED STUDY COMPARING PENICILLIN, ERYTHROMYCIN AND CLINDAMYCIN. I t z h a k Brook and Ronald Hierkawa. Depts. P e d i a t r i c s and O t o l a r y n g -U m m e d S m s Univers i t y o f t h e H e a l t h Sciences and t h e Naval Medical Research I n s t it u t e . Bethesda, Maryland 20814 F o r t y -f i v e p a t i e n t s who suffered from r e c u r r e n t t o n s i l l i t i s due t o Group A b e t a h a e m o l y t i c s t r e p t o c o c c i (GABHS) p a r t i c i p a t e d
i n a p r o s p e c t i v e randomized study comparing p e n i c i l l i n , e r y t h r omycin o r c l i n d a m y c i n therapy. Surface t o n s i l l a r c u l t u r e s were o b t a i n e d p r i o r t o therapy, 1 0 days a f t e r t e r m i n a t i o n o f therapy and once a month f o r a p e r i o d o f 12-18 months. They were processed f o r a e r o b i c and anaerobic microorganisms. Mixed a e r o b i c and anaerobic f l o r a were o b t a i n e d from a l l c u l t u r e s . Beta lactamase-producing a e r o b i c and anaerobic b a c t e r i a were p r e s e n t i n 43 o f t h e 45 (93%) t o n s i l l a r c u l t u r e s .
A d m i n i s t r a t i o n of p e n i c i l l i n e r a d i c a t e d GABHS i n 2 o f 15 p a t i e n t s , e r y t h r o m y c i n i n 6 o f 15 and c l i n d a m y c i n i n 14 o f t h e 15. Of t h e p a t i e n t s t h a t were f o l l o w e d up, 12 o f 14 p a t i e n t s t r e a t e d w i t h p e n i c i l l i n and 6 o f 14 p a t i e n t s t r e a t e d w i t h erythromycin, and 1 o f 15 t r e a t e d w i t h c l i n d a m y c i n continued t o s u f f e r from r e c u r r e n t t o n s i l l i t i s . Four p a t i e n t s who were t r e a t e d w i t h p e n i c i l l i n and two t r e a t e d w i t h e r y t h r o m y c i n had t h e i r t o n s i l s removed. T h i s study demons t r a t e s t h e e f f i c a c y o f clindamycin, an a n t i m i c r o b i a l e f f e c t i v e a g a i n s t GABHS, and b o t h a e r o b i c and anaerobic b e t a lactamasep r o d u c i n g organisms, i n p r e v e n t i o n o f r e c u r r e n t t o n s i l l i t i s .
DIFFERENTIATION OF VARICELLA VACCINE FROM
1048 WILDSTRAINS. P h i l i p A. B r u n e l l , and E l a i n e K.
Cobb. U.T. H e a l t h Science Center. D e~a r t m e n t o f . .
Pediatrics,%Antonio, Texas. V a r i c e l l a vaccine (VV) r e c i p i e n t s have occasional 1 y developed s i g n i f i c a n t i l l n e s s f o l l o w i n g immunization.
It i s necessary t o a s c e r t a i n whether t h e s e i l l n e s s e s a r e produced by VV o r by n a t u r a l i n f e c t i o n . V i r u s was i s o l a t e d from one vaccine r e c i p i e n t 26 and 28 days p o s t immunization. These i s o l a t e s , (Lo26 and Lo28) were t e s t e d t o g e t h e r w i t h e a r l y and l a t e passage vaccine, (Oka) s t r a i n ; 3 w i l d i s o l a t e s ; and a l a b o r a t o r y , ( E l l e n ) s t r a i n . VZ i n f e c t e d c e l l s were l y s e d and t h e n t r e a t e d t o remove normal c e l l components. The v i r u s was t h e n t r e a t e d w i t h SDS t o r e l e a s e v i r a l DNA which was p u r i f i e d and d i g e s t e d w i t h a v a r i e t y o f r e s t r i c t i o n enzymes (RE). The d i g e s t s were etectrophoresed i n agarose g e l s c o n t a i n i n g e t h i d i u m bromide. Two t y p e s o f p a t t e r n s were observed. One, found w i t h s e v e r a l enzymes, revealed minor changes r e f l e c t i n g p r e v i o u s l y described v a r i a b l e regions. The second, seen o n l y w i t h P s t 1, c l e a r l y d i f f e r e n t i a t e d vaccine and Lo26 and Lo28 from t h e others. D i f f e r e n c e s observed appear t o r e s u l t from t h e d e l e t i o n o f a P s t 1 RE s i t e i n t h e l o n g segment o f vaccine VZ DNA. This change was a1 ready present i n e a r l y passage o f t h e Oka s t r a i n w h i l e t h e E l l e n s t r a i n r e t a i n e d t h i s s i t e d e s p i t e over 150 t i s s u e c u l t u r e passages. P s t 1 c h a r a c t e r i z a t i o n o f VZ DNA o b t a i n e d from i s o l a t e s w i l l be u s e f u l i n d e t e r m i n i n g whether rashes i n vaccinees o r t h e i r c o n t a c t s a r e due t o vaccine o r r e s u l t from unrecognized w i l d VZ i n f e c t i o n . It w i l l a l s o h e l p t o c h a r a c t e r i z e i s o l a t e s from vaccinees who develop zoster. We examined nasal secretions (NS) of 13 patients (pts) age 1-8 months ( m s ) hospitalized with acute RSV infection for IgA Ab to the surface glycoproteins (66K and 84K) and nucleocapsid protein (NCP) of RSV. Acute and convalescent (conv) NS (obtained 3-17 days ld) after initial NS) were examined by enzyme-linked immunosorbent assay (ELISA) using individual mouse monoclonal Abs (RSV Long strain) to GGK, 8 4 K , and NCP and RSV hyperimmune horse serum (HA-) as capture Abs. Competition assays demonstrated that the antigens captured in this system were specific for each monoclonal Ab used. Total IqA Ab to RSV measured by HARS showed a 2 3-fold rise in Ab titer in 9/13 pts. Ab rise (2 3-fold) to G6K (fusion) qlycoprotein occurred in 5/13 pts; 84K, 3/13 pts; and NCP, 6/13 pts. Ab rise was most striking in the 7 pts with later conv NS (2 6 d after acute NS). All but the youngest (1 mo) of these 7 pts had a 2 3-fold rise in total RSV Ab measured by HARS capture. Three, 2, and 4 of these pts had Ab rises to the 66K, 84K, and NCP respectively. Only 2/13 pts, both aged 1 mo, had no detectable RSV-specific Ab in NS.
Ab rise in the remaining pts could not be explained by differences in IqA content between acute and conv NS. We conclude that monoclonal Ab capture ELISA can be used to detect classspecific Ab in infant NS and that infants recovering from RSV make IgA Ab to NCP and both surface qlycoproteins.
